Assessment of Phase 3 Randomized Clinical Trials Including Patients With Leptomeningeal Disease
Alisha Sharma, Kathryn Corbett, Hany Soliman, Arjun Sahgal, Sunit Das, Mary Jane Lim-Fat, Katarzyna J. Jerzak
Abstract
This systematic review examines the proportion of patients with leptomeningeal disease included in phase 3 randomized clinical trials for patients with metastatic breast cancer, lung cancer, and melanoma.
Topics & Concepts
MedicineRandomized controlled trialBreast cancerLung cancerDiseaseClinical trialMelanomaCancerInternal medicineOncologyCancer researchBrain Metastases and TreatmentGlioma Diagnosis and TreatmentCancer Treatment and Pharmacology